| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diarrhea | D003967 | 32 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Fractures, Spontaneous | D005598 | 4 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Intraoperative Complications | D007431 | 5 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Hyperbilirubinemia | D006932 | 11 associated lipids |
| Anaphylaxis | D000707 | 35 associated lipids |
Rifamycin SV
Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.
Cross Reference
Introduction
To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Rifamycin SV?
Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Rifamycin SV
PubChem Associated disorders and diseases
What pathways are associated with Rifamycin SV
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Rifamycin SV?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Rifamycin SV?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
What genes are associated with Rifamycin SV?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Rifamycin SV
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Li W et al. | Development of a sensitive and rapid method for rifampicin impurity analysis using supercritical fluid chromatography. | 2015 | J Pharm Biomed Anal | pmid:26103526 |
| Li Q et al. | [Ocular syndromes in patients with neurobrucellosis]. | 2015 | Zhonghua Yan Ke Za Zhi | pmid:26888270 |
| Sayyed K et al. | Alteration of human hepatic drug transporter activity and expression by cigarette smoke condensate. | 2016 | Toxicology | pmid:27450509 |
| Alsdurf H et al. | The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. | 2016 | Lancet Infect Dis | pmid:27522233 |
| Vékey K et al. | Liquid chromatographic-mass spectrometric studies on rifamycin antibiotics. | 1989 | J. Chromatogr. | pmid:2768398 |
| Bi YA et al. | Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. | 2017 | AAPS J | pmid:28188574 |
| Quinlan GJ and Gutteridge JM | Oxygen radical damage to DNA by rifamycin SV and copper ions. | 1987 | Biochem. Pharmacol. | pmid:2823829 |
| Narang SS et al. | Molecular insights into the inhibitory mechanism of rifamycin SV against β-microglobulin aggregation: A molecular dynamics simulation study. | 2017 | Int. J. Biol. Macromol. | pmid:28455257 |
| Lin SW et al. | Rifamycin SV MMX for the treatment of traveler's diarrhea. | 2017 | Expert Opin Pharmacother | pmid:28697313 |
| Qi F et al. | Deciphering the late steps of rifamycin biosynthesis. | 2018 | Nat Commun | pmid:29904078 |
| Zhang Y et al. | GlnR positive transcriptional regulation of the phosphate-specific transport system pstSCAB in Amycolatopsis mediterranei U32. | 2018 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:30007316 |
| Testa A et al. | Preclinical Evaluation of [F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters. | 2018 | Contrast Media Mol Imaging | pmid:30154685 |
| Gao DZ | [Determination of rifampin, rifamdin and rifocin concentrations in the CSF of 71 patients with tuberculous meningitis]. | 1986 | Zhonghua Yi Xue Za Zhi | pmid:3094900 |
| Hanzlik J et al. | [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"]. | 1986 | Ann Univ Mariae Curie Sklodowska Med | pmid:3154057 |
| Passamonti S and Sottocasa GL | The quinoid structure is the molecular requirement for recognition of phthaleins by the organic anion carrier at the sinusoidal plasma membrane level in the liver. | 1988 | Biochim. Biophys. Acta | pmid:3401473 |
| Caruso I | Rifamycin SV in the local treatment of synovitis. | 1987 | J. Rheumatol. | pmid:3572924 |
| Yu WH et al. | [Study of incompatibility in vitro of injection of rifamycin sodium with 45 injections]. | 1986 | Hua Xi Yi Ke Da Xue Xue Bao | pmid:3804311 |
| Furet Y et al. | [Mixed hepatitis due to rifamycin SV. Apropos of a case]. | 1986 Sep-Oct | Therapie | pmid:3810533 |
| Babasaki K et al. | Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis 168: isolation, structural analysis, and biogenesis. | 1985 | J. Biochem. | pmid:3936839 |
| Gentile S et al. | Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: evidence of a functional heterogeneity. | 1985 | Hepatogastroenterology | pmid:4018705 |
| Lindblad S et al. | Rifamycin SV in local treatment of synovitis--a clinical, arthroscopic and pharmacologic evaluation. | 1985 | J. Rheumatol. | pmid:4087269 |
| Medoff G et al. | Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B. | 1973 | Cancer Res. | pmid:4352361 |
| Cricchio R and Tamborini G | A new series of semisynthetic rifamycins. N derivatives of 4-amino-4-deoxyrifamycin SV. | 1971 | J. Med. Chem. | pmid:4398855 |
| Erickson RJ and Grosch JC | Isolation and characterization of a polynucleotide phosphorylase from Bacillus amyloliquefaciens. | 1977 | J. Bacteriol. | pmid:45489 |
| Kenwright S and Levi AJ | Sites of competition in the selective hepatic uptake of rifamycin-SV, flavaspidic acid, bilirubin, and bromsulphthalein. | 1974 | Gut | pmid:4842968 |
| Maggi N et al. | New derivatives of rifamycin SV. | 1965 | Antimicrob Agents Chemother (Bethesda) | pmid:4956802 |
| Nitti V | The antituberculous activity of rifamycin SV. | 1965 | Helv Med Acta | pmid:4958120 |
| Gentile S et al. | [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers]. | 1979 | Boll. Soc. Ital. Biol. Sper. | pmid:552849 |
| Marchi E et al. | [New derivatives of rifamycin SV. Esters, hydrazide amides of 3-carboxyrifamycin SV]. | 1979 Jan-Dec | G Ital Chemioter | pmid:554811 |
| Okolicsanyi L et al. | [Effect of rifamycin SV on the metabolism of bile salts in the rat]. | 1979 Jan-Dec | G Ital Chemioter | pmid:554815 |
| Kradolfer F et al. | Chemotherapeutic activity of new derivatives of rifamycin. | 1966 | Antimicrob Agents Chemother (Bethesda) | pmid:5985258 |
| Xiao-Chang F et al. | Biochemical study of R-75-1, a new semi-synthetic rifamycin. | 1981 | J. Antibiot. | pmid:6168632 |
| Revuz J et al. | [Generalization of zona in a nonimmunosuppressed patient receiving isoprinosine and rifamycin SV]. | 1983 | Ann Dermatol Venereol | pmid:6195953 |
| Amagai T et al. | The effect of ribavirin and rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice. | 1982 | Immunol. Lett. | pmid:6210629 |
| Kono Y | Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide. | 1982 | J. Biochem. | pmid:6279585 |
| Kono Y and Sugiura Y | Electron spin resonance studies on the oxidation of rifamycin SV catalyzed by metal ions. | 1982 | J. Biochem. | pmid:6279586 |
| Păunescu E et al. | [Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis]. | 1982 Apr-Jun | Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol | pmid:6294806 |
| Freymuth F et al. | [In vitro activity of rifamycin SV on herpes simplex and herpes varicella viruses]. | 1983 May-Jun | Therapie | pmid:6310814 |
| Bruni L et al. | Herpes zoster treatments: results of a clinical trial relative to the use of rifamycin SV versus neuramide. | 1984 | J. Int. Med. Res. | pmid:6381169 |
| Deshko TN et al. | [Physico-chemical properties of DNA-dependent RNA-polymerase from Escherichia coli and its subunits]. | 1984 | Bioorg. Khim. | pmid:6388581 |
| Brufani M et al. | The synthesis of 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives. | 1984 | J. Antibiot. | pmid:6526730 |
| Craven N and Anderson JC | Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. | 1983 | Am. J. Vet. Res. | pmid:6553464 |
| Vogt E | [Effects of rifamycin SV and a neomycin-bacitracin combination on the healing of microbial eczema]. | 1983 | Z. Hautkr. | pmid:6649743 |
| Dekio S and Jidoi J | Mechanism of coagulase production in Staphylococcus aureus Smith. | 1983 | Zentralbl Bakteriol Mikrobiol Hyg A | pmid:6673416 |
| Gentile S et al. | Plasma clearance of nicotinic acid and rifamycin-SV, and their interaction in Gilbert's syndrome: application of a compartmental model. | 1984 | Hepatogastroenterology | pmid:6724499 |
| Nikiforov VG et al. | A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli. | 1982 | FEBS Lett. | pmid:6761147 |
| Arora SK | Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV. | 1983 | Mol. Pharmacol. | pmid:6865897 |
| Bruni L et al. | Preliminary results of a clinical trial relative to the use of rifamycin SV in the treatment of herpes zoster. | 1980 | J. Int. Med. Res. | pmid:6987112 |
| Karaivanov L et al. | [Attempt at eliminating the multiple drug resistance of E. coli in pigs with enteritis using Rimactin]. | 1980 | Vet Med Nauki | pmid:7015689 |
| Caruso I et al. | Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. | 1982 | Ann. Rheum. Dis. | pmid:7046652 |